8-K//Current report
Inhibikase Therapeutics, Inc. 8-K
Accession 0001193125-25-180889
$IKTCIK 0001750149operating
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:56 PM ET
Size
3.3 MB
Accession
0001193125-25-180889
Documents
- 8-Kd946023d8k.htmPrimary
8-K
- EX-99.1d946023dex991.htm
EX-99.1
- EX-99.2d946023dex992.htm
EX-99.2
- EX-101.SCHikt-20250814.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABikt-20250814_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREikt-20250814_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- GRAPHICg946023ex99_2s10g1.jpg
GRAPHIC
- GRAPHICg946023ex99_2s11g1.jpg
GRAPHIC
- GRAPHICg946023ex99_2s12g1.jpg
GRAPHIC
- GRAPHICg946023ex99_2s13g1.jpg
GRAPHIC
- GRAPHICg946023ex99_2s14g1.jpg
GRAPHIC
- GRAPHICg946023ex99_2s15g1.jpg
GRAPHIC
- GRAPHICg946023ex99_2s16g1.jpg
GRAPHIC
- GRAPHICg946023ex99_2s17g1.jpg
GRAPHIC
- GRAPHICg946023ex99_2s18g1.jpg
GRAPHIC
- GRAPHICg946023ex99_2s19g1.jpg
GRAPHIC
- GRAPHICg946023ex99_2s1g1.jpg
GRAPHIC
- GRAPHICg946023ex99_2s20g1.jpg
GRAPHIC
- GRAPHICg946023ex99_2s21g1.jpg
GRAPHIC
- GRAPHICg946023ex99_2s22g1.jpg
GRAPHIC
- GRAPHICg946023ex99_2s23g1.jpg
GRAPHIC
- GRAPHICg946023ex99_2s24g1.jpg
GRAPHIC
- GRAPHICg946023ex99_2s2g1.jpg
GRAPHIC
- GRAPHICg946023ex99_2s3g1.jpg
GRAPHIC
- GRAPHICg946023ex99_2s4g1.jpg
GRAPHIC
- GRAPHICg946023ex99_2s5g1.jpg
GRAPHIC
- GRAPHICg946023ex99_2s6g1.jpg
GRAPHIC
- GRAPHICg946023ex99_2s7g1.jpg
GRAPHIC
- GRAPHICg946023ex99_2s8g1.jpg
GRAPHIC
- GRAPHICg946023ex99_2s9g1.jpg
GRAPHIC
- GRAPHICg946023g58z24.jpg
GRAPHIC
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-25-180889-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLd946023d8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Inhibikase Therapeutics, Inc.
CIK 0001750149
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001750149
Filing Metadata
- Form type
- 8-K
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 4:56 PM ET
- Size
- 3.3 MB